The Irish Times

Irish pharma firm Amryt nears approval for butterfly skin treatment

EMA has 67 days to decide whether to back recommendation of its expert committee

Fri Apr 22 2022 - 19:47

Rare disease specialist Amryt lost €65m last year

Irish drug-maker plans to return $30m to investors

Wed Mar 09 2022 - 18:51

Amryt announces plan to delist from AIM in London

Drug firm says says delisting would enhance liquidity of trading

Mon Nov 22 2021 - 07:33

Irish pharma group Amryt reports 15% revenue growth for third quarter

Rare disease specialist says performance was ‘strong’ in ‘extremely busy’ period

Wed Nov 03 2021 - 13:12

Record sales for Irish rare disease specialist Amryt

Company upgrades forecasts as it completes Chiasma takeover

Fri Aug 06 2021 - 20:03

Amryt Pharma granted priority review of ‘butterfly skin’ treatment

US Food and Drug Administration’s priority review can expedite review process to six months

Thu Jun 03 2021 - 07:35

Dublin-based Amryt buys US firm Chiasma in deal worth $330m

Drug group expands its portfolio of medicines while reporting first-quarter numbers

Wed May 05 2021 - 19:31

Amryt progresses with bid to win US approval for ‘butterfly skin’ treatment

Rolling submission began last summer

Wed Mar 31 2021 - 15:04

Amryt sales hit record $182m last year

Company developing drug for rare butterfly skin condition

Thu Mar 04 2021 - 15:34

Biopharma group Amryt reports 19% jump in revenue in third quarter

Results are a record for Dublin-based company, which has recently listed on Nasdaq

Thu Nov 05 2020 - 19:32

Amryt signs agreement to distribute Lojuxta

Swixx BioPharma will sell cholesterol drug across central and eastern Europe

Mon Oct 19 2020 - 07:31

Amryt shares surge on success in drug trial for ‘butterfly skin’

Irish specialist in rare diseases says successful drug could tap $1bn market

Wed Sept 09 2020 - 19:07

EY Entrepreneur of the Year international finalists focusing on growth

Sectors include health and safety, pharma, crop protection and refrigeration

Sat Sept 05 2020 - 05:00

Irish pharma company Amryt almost doubles CEO pay to $1.6m

Chief executive Joe Wiley also received more than 6m share options in company

Tue Jun 30 2020 - 12:39

Biopharma group Amryt reports 30% jump in revenue

Rare disease specialist says integration with newly acquired Aegerion completed ahead of time

Mon May 11 2020 - 09:20

Amryt Pharma recorded 13.1% rise in revenue last year

Company said the impact of Covid-19 on its business has been minimised so far

Mon Mar 23 2020 - 12:06

Amryt says integration of acquired company Aegerion ‘progressing well’

Dublin-based biopharma company has cash position of $60.9m

Thu Dec 19 2019 - 08:26

Dublin pharma company Amryt grows sales almost 20%

Firm acquired US-based Aegerion Pharmaceuticals earlier this year

Tue Nov 05 2019 - 10:09

Amryt acquires company with plans to grow portfolio

Group plots dual Nasdaq listing to create enlarged rare disease company

Tue May 21 2019 - 08:15

Amryt gets 2019 off to strong start following 13% revenue rise in 2018

Lojuxta revenues driven by UK, France reimbursement approval

Wed Apr 17 2019 - 18:53

Carrick Therapeutics head Sullivan named best emerging entrepreneur

Elaine Sullivan leads cancer research firm to an EY Entrepreneur of the Year Award

Thu Oct 25 2018 - 19:00

Sales of Amryt Pharma cholesterol drug up 14.6%

Amyrt’s EB development asset progressing through phase three clinical trial

Wed Sept 26 2018 - 08:01

Amryt skin therapy trial gets green light in US

Approval for treatment for rare genetic condition paves way for clinical trials in US

Mon Sept 10 2018 - 07:27

Amryt Pharma wins key US drug designation

FDA move means Irish company could receive voucher ultimately worth up to €300m

Thu Aug 02 2018 - 15:04

Amryt Pharma heart drug wins approval from NHS England

Drug treats rare condition which can lead to early blocking of arteries and heart attacks

Mon Jul 09 2018 - 08:09

Dublin entrepreneur targeting treatments for rare diseases

EY Entrepreneur of the Year finalist Dr Joe Wiley of Amryt Pharma

Mon Jun 25 2018 - 04:00

Amryt signs new deal to expand Lojuxta licence

Firms estimates new deal will increase number of patients for treatment by 25%

Thu May 10 2018 - 09:58

EY Entrepreneur of the Year: 24 companies shortlisted for award

Finalists employ more than 2,700 people and generate annual revenues of €150m

Mon Apr 23 2018 - 00:01

Amryt reports strong 2017 as revenues rise to almost €13m

Biopharma firm signs new deal for gene therapy that could treat genetic condition EB

Thu Mar 15 2018 - 07:46

Amryt Pharma signs distribution agreement in middle east

Company has further expanded its market coverage for Lojuxta

Tue Mar 06 2018 - 07:47

Amryt signs new distribution deal for Lojuxta

Latest deal is fourth in three months for Ierish biopharmaceutical company

Tue Jan 30 2018 - 08:59

Amryt Pharma appoints new head of regulatory affairs

Derval O’Carroll has more than 25 years experience in pharmaceutical industry

Wed Jan 24 2018 - 08:58

Amryt Pharma signs deal for drug distribution in Switzerland

Lojuxta deal is ‘key step’ in growing company’s business for drug in EMEA region

Mon Jan 08 2018 - 08:23

Amryt Pharma to raise €15m to treat rare skin disorder

Placing is conditional on shareholder approval at a general meeting on October 9th

Thu Sept 21 2017 - 07:26